{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:33:41Z","timestamp":1759962821589},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T00:00:00Z","timestamp":1272585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1472-6947-10-24","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T18:14:54Z","timestamp":1272651294000},"source":"Crossref","is-referenced-by-count":11,"title":["Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model"],"prefix":"10.1186","volume":"10","author":[{"given":"Nicolas M","family":"Furiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Kahle-Wrobleski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R","family":"Siemers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Sarpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,30]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00002093-200110000-00002","volume":"15","author":"LE Hebert","year":"2001","unstructured":"Hebert LE, Beckett LA, Scherr PA, Evans DA: Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord. 2001, 15: 169-173. 10.1097\/00002093-200110000-00002.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"325_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","volume":"60","author":"LE Hebert","year":"2003","unstructured":"Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003, 60: 1119-1122. 10.1001\/archneur.60.8.1119.","journal-title":"Arch Neurol"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","volume":"4","author":"H Hampel","year":"2008","unstructured":"Hampel H, Burger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K: Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 2008, 4: 38-48. 10.1016\/j.jalz.2007.08.006.","journal-title":"Alzheimers Dement"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/157488408784293723","volume":"3","author":"SV Frankfort","year":"2008","unstructured":"Frankfort SV, Tulner LR, van Campen JP, Verbeek MM, Jansen RW, Beijnen JH: Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr Clin Pharmacol. 2008, 3: 123-131. 10.2174\/157488408784293723.","journal-title":"Curr Clin Pharmacol"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1212\/01.wnl.0000287091.57376.65","volume":"70","author":"AS Fleisher","year":"2008","unstructured":"Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC: Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology. 2008, 70: 191-199. 10.1212\/01.wnl.0000287091.57376.65.","journal-title":"Neurology"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/01.wnl.0000258542.58725.4c","volume":"68","author":"AS Fleisher","year":"2007","unstructured":"Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ: Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2007, 68: 1588-1595. 10.1212\/01.wnl.0000258542.58725.4c.","journal-title":"Neurology"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000100926","volume":"23","author":"O Hansson","year":"2007","unstructured":"Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L: Prediction of Alzheimer's disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment. Dement Geriatr Cogn Disord. 2007, 23: 316-320. 10.1159\/000100926.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006, 5: 228-234. 10.1016\/S1474-4422(06)70355-6.","journal-title":"Lancet Neurol"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/00005392-199909010-00032","volume":"162","author":"R Etzioni","year":"1999","unstructured":"Etzioni R, Cha R, Cowen ME: Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies. J Urol. 1999, 162: 741-748. 10.1097\/00005392-199909010-00032.","journal-title":"J Urol"},{"key":"325_CR10","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/j.1572-0241.2000.02172.x","volume":"95","author":"RM Ness","year":"2000","unstructured":"Ness RM, Holmes AM, Klein R, Dittus R: Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol. 2000, 95: 1800-1811. 10.1111\/j.1572-0241.2000.02172.x.","journal-title":"Am J Gastroenterol"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1040-8428(99)00033-5","volume":"32","author":"K Perez-Niddam","year":"1999","unstructured":"Perez-Niddam K, Thoral F, Charvet-Protat S: Economic evaluation of a prostate cancer screening program in France: a decision model. Crit Rev Oncol Hematol. 1999, 32: 167-173. 10.1016\/S1040-8428(99)00033-5.","journal-title":"Crit Rev Oncol Hematol"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1157\/13125585","volume":"31","author":"F Rodriguez-Moranta","year":"2008","unstructured":"Rodriguez-Moranta F, Trapero-Bertran M, Castells A, Mas-Canal X, Balaguer F, Pellise M: Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model. Gastroenterol Hepatol. 2008, 31: 405-412. 10.1157\/13125585.","journal-title":"Gastroenterol Hepatol"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2174\/138161208784746833","volume":"14","author":"A Tramarin","year":"2008","unstructured":"Tramarin A, Gennaro N, Compostella FA, Gallo C, Wendelaar Bonga LJ, Postma MJ: HCV screening to enable early treatment of hepatitis C: a mathematical model to analyse costs and outcomes in two populations. Curr Pharm Des. 2008, 14: 1655-1660. 10.2174\/138161208784746833.","journal-title":"Curr Pharm Des"},{"key":"325_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1472-6947-8-40","volume":"8","author":"JD Keen","year":"2008","unstructured":"Keen JD, Keen JE: How does age affect baseline screening mammography performance measures? A decision model. BMC Med Inform Decis Mak. 2008, 8: 40-10.1186\/1472-6947-8-40.","journal-title":"BMC Med Inform Decis Mak"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1495::AID-SIM441>3.0.CO;2-E","volume":"19","author":"A Beiser","year":"2000","unstructured":"Beiser A, D'Agostino RB, Seshadri S, Sullivan LM, Wolf PA: Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000, 19: 1495-1522. 10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1495::AID-SIM441>3.0.CO;2-E.","journal-title":"Stat Med"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1212\/WNL.49.6.1498","volume":"49","author":"S Seshadri","year":"1997","unstructured":"Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R: Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology. 1997, 49: 1498-1504.","journal-title":"Neurology"},{"key":"325_CR17","unstructured":"U.S. Census Bureau: Annual Estimates of the Resident Population by Sex and Five-Year Age Groups for the United States: April 1, 2000 to July 1, 2008. [ http:\/\/www.census.gov\/popest\/states\/NST-ann-est.html ]"},{"key":"325_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/1315575.1315579","volume":"18","author":"S Roberts","year":"2008","unstructured":"Roberts S, Wang L, Klein R, Ness R, Dittus R: Development of a Simulation Model of Colorectal Cancer. ACM Transactions on Modeling and Computer Simulation. 2008, 18: 1-30. 10.1145\/1315575.1315579.","journal-title":"ACM Transactions on Modeling and Computer Simulation"},{"key":"325_CR19","volume-title":"Simulation Modeling & Analysis","author":"MA Law","year":"2006","unstructured":"Law MA: Simulation Modeling & Analysis. 2006, Boston, McGraw-Hill Science Engineering, 4","edition":"4"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/003754978404300406","volume":"43","author":"RW Klein","year":"1984","unstructured":"Klein RW, Roberts SD: A Time-varying Poisson Arrival Process Generator. Simulation. 1984, 43: 193-195. 10.1177\/003754978404300406.","journal-title":"Simulation"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/cncr.22485","volume":"109","author":"TI Barron","year":"2007","unstructured":"Barron TI, Connolly R, Bennett K, Feely J, Kennedy MJ: Early discontinuation of tamoxifen: a lesson for oncologists. Cancer. 2007, 109: 832-839. 10.1002\/cncr.22485.","journal-title":"Cancer"},{"issue":"2","key":"325_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neurobiolaging.2007.06.009","volume":"30","author":"O Hansson","year":"2009","unstructured":"Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S: Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging. 2009, 30 (2): 165-73. 10.1016\/j.neurobiolaging.2007.06.009.","journal-title":"Neurobiol Aging"},{"key":"325_CR23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1345\/aph.1E548","volume":"39","author":"S Perreault","year":"2005","unstructured":"Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L: Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother. 2005, 39: 1401-1408. 10.1345\/aph.1E548.","journal-title":"Ann Pharmacother"},{"key":"325_CR24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.18553\/jmcp.2008.14.5.451","volume":"14","author":"L Mucha","year":"2008","unstructured":"Mucha L, Shaohung S, Cuffel B, McRae T, Mark TL, Del Valle M: Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease. J Manag Care Pharm. 2008, 14: 451-461.","journal-title":"J Manag Care Pharm"},{"key":"325_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.18553\/jmcp.2005.11.3.231","volume":"11","author":"JA Mauskopf","year":"2005","unstructured":"Mauskopf JA, Paramore C, Lee WC, Snyder EH: Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. J Manag Care Pharm. 2005, 11: 231-251.","journal-title":"J Manag Care Pharm"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00002512-200522080-00006","volume":"22","author":"DC Suh","year":"2005","unstructured":"Suh DC, Thomas SK, Valiyeva E, Arcona S, Vo L: Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease. Drugs Aging. 2005, 22: 695-707. 10.2165\/00002512-200522080-00006.","journal-title":"Drugs Aging"},{"key":"325_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1365-2125.2005.02355.x","volume":"59","author":"S Perreault","year":"2005","unstructured":"Perreault S, Blais L, Lamarre D, Dragomir A, Berbiche D, Lalonde L: Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol. 2005, 59: 564-573. 10.1111\/j.1365-2125.2005.02355.x.","journal-title":"Br J Clin Pharmacol"},{"key":"325_CR28","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0149-2918(00)80025-9","volume":"21","author":"L Jonsson","year":"1999","unstructured":"Jonsson L, Lindgren P, Wimo A, Jonsson B, Winblad B: The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model. Clin Ther. 1999, 21: 1230-1240. 10.1016\/S0149-2918(00)80025-9.","journal-title":"Clin Ther"},{"key":"325_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/(SICI)1099-1166(199807)13:7<445::AID-GPS794>3.0.CO;2-E","volume":"13","author":"A Stewart","year":"1998","unstructured":"Stewart A, Phillips R, Dempsey G: Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil. Int J Geriatr Psychiatry. 1998, 13: 445-453. 10.1002\/(SICI)1099-1166(199807)13:7<445::AID-GPS794>3.0.CO;2-E.","journal-title":"Int J Geriatr Psychiatry"},{"key":"325_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1532-5415.1999.tb02572.x","volume":"47","author":"BJ O'Brien","year":"1999","unstructured":"O'Brien BJ, Goeree R, Hux M, Iskedjian M, Blackhouse G, Gagnon M: Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada. J Am Geriatr Soc. 1999, 47: 570-578.","journal-title":"J Am Geriatr Soc"},{"key":"325_CR31","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1212\/WNL.52.6.1138","volume":"52","author":"PJ Neumann","year":"1999","unstructured":"Neumann PJ, Hermann RC, Kuntz KM, Araki SS, Duff SB, Leon J: Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology. 1999, 52: 1138-1145.","journal-title":"Neurology"},{"key":"325_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1525-1497.2005.0116.x","volume":"20","author":"JS Mandelblatt","year":"2005","unstructured":"Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Extermann M: Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med. 2005, 20: 487-496. 10.1111\/j.1525-1497.2005.0116.x.","journal-title":"J Gen Intern Med"},{"key":"325_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0168-8510(95)00720-D","volume":"34","author":"D Gyrd-Hansen","year":"1995","unstructured":"Gyrd-Hansen D, Holund B, Andersen P: A cost-effectiveness analysis of cervical cancer screening: health policy implications. Health Policy. 1995, 34: 35-51. 10.1016\/0168-8510(95)00720-D.","journal-title":"Health Policy"},{"key":"325_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.7326\/0003-4819-137-2-200207160-00015","volume":"137","author":"M Pignone","year":"2002","unstructured":"Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN: Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002, 137: 132-141.","journal-title":"Ann Intern Med"},{"key":"325_CR35","volume-title":"Economic Models of Colorectal Cancer Screening in Average-Risk Adults","author":"M Pignone","year":"2005","unstructured":"Pignone M, Russell L, Wagner J: Economic Models of Colorectal Cancer Screening in Average-Risk Adults. 2005, The National Academies Press Washington, D.C"},{"key":"325_CR36","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","volume":"360","author":"GL Andriole","year":"2009","unstructured":"Andriole GL, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009, 360: 1310-1319. 10.1056\/NEJMoa0810696.","journal-title":"N Engl J Med"},{"key":"325_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004, 256: 183-194. 10.1111\/j.1365-2796.2004.01388.x.","journal-title":"J Intern Med"},{"issue":"Suppl 1","key":"325_CR38","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1017\/S0317167100005497","volume":"34","author":"RW Bouchard","year":"2007","unstructured":"Bouchard RW: Diagnostic criteria of dementia. Can J Neurol Sci. 2007, 34 (Suppl 1): S11-S18.","journal-title":"Can J Neurol Sci"},{"key":"325_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/jnnp.2008.160705","volume":"80","author":"J Saxton","year":"2009","unstructured":"Saxton J, Snitz BE, Lopez OL, Ives DG, Dunn LO, Fitzpatrick A: Functional and Cognitive Criteria Produce Different Rates of MCI. J Neurol Neurosurg Psychiatry. 2009, 80: 737-743. 10.1136\/jnnp.2008.160705.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"325_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00012","volume":"137","author":"LL Humphrey","year":"2002","unstructured":"Humphrey LL, Helfand M, Chan BK, Woolf SH: Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002, 137: 347-360.","journal-title":"Ann Intern Med"},{"key":"325_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/ewjm.173.5.307","volume":"173","author":"LM Schwartz","year":"2000","unstructured":"Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG: US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey. West J Med. 2000, 173: 307-312. 10.1136\/ewjm.173.5.307.","journal-title":"West J Med"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-10-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-10-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-10-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-10-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:43:31Z","timestamp":1635295411000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-10-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-10-24","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,30]]},"article-number":"24"}}